Navigation Links
Leukaemia May Be Triggered By Insecticides

A research conducted by French doctors has revealed that those children who are exposed to head lice shampoos and insecticides run a higher chance of contracting childhood leukaemia. The Occupational and Environmental Medicine journal //has published this report. The study has cautioned against exposing children to mosquito repellents also.

The France based Inserm had conducted the study upon 280 children. Extensive interviews were carried out with mothers of such children. The chances of acute leukaemia was found to be higher in the case of mothers who had used insecticides inside the house while they were pregnant. The carbamates compound which is present in products like insect sprays and lice shampoos are reportedly directly connected to leukaemia.

The carbamates which are most commonly used in the UK are carbosulfan, carbofuran and carbaryl. A government committee has already given a warning with regard to products which contain carbaryl. Leukaemia is in effect a cancer of the blood cells. There are about 500 children in the UK who are diagnosed with the disease every year, among whom about 100 die.

Male children run a greater chance of contracting this disease than female children. The disease usually develops in the womb, and it is later triggered during childhood. Studies are still being conducted to determine as to whether this is due to dietary, environmental, or genetic conditions.


'"/>




Page: 1

Related medicine news :

1. Moms Stomach Bacteria Can Cause Leukaemia In Children
2. Southeast Asian Children With Leukaemia To Get New Treatment
3. Good And Evil Clones Of Acute Lymphoblastic Leukaemia cells
4. Asthma Attacks May Be Triggered By Inhalers
5. Doctors Predict an Asthma Epidemic Triggered by Thunderstorms
6. Knee Osteoarthritis May Be Triggered By Low Levels Of Estrogen
Post Your Comments:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...al type of MRSA affecting almost double the number...ears statistics, has raised concerns in medical ci...that almost 150 children were down with a virulent...the super bug from NHS hospitals. 75% of the affec...
... in drug resistant bacterial infections scientists...hat stop the bacteria’s ability to spread infectio... benign rather killed. This development shows prom... light of several antibiotics losing their potency...
... for prevention of chikungunya and dengue fever in... of Public Health//. Aedes aegypti, mosquito is t...s and dengue causing virus. Hence, the state has t...rogramme involving 35,000 health workers and volun...
...ntrations commonly sold on the street, causes the ...scle – a process causing heart enlargement that ca...chers at the University of South Florida College o...’ Hospital. The study was published in the July 2...
Other Medicine News:Health News:Latest Weapon in Battle against Drug-Resistant Bacteria 2Health News:Researchers Identify Key Step in Cocaine-Induced Heart Enlargement, Sudden Death 2
(Date:9/4/2008)...wswire/ -- Axentis Pharma AG has,initiated a clini...ability,of a new therapeutic formulation for the t...ibrosis patients. The new formulation allows an,es...ly to the site of,infection. The forthcoming trial...ses of the new drug. Initial results are expected ...
(Date:9/3/2008)...ewswire-FirstCall/ --,Pharmaceutical company Pharm... it has enrolled the first subject into its second...tol in cystic fibrosis sufferers., The Phase 3 tr...h,America, Argentina and Germany, and is the final...market Bronchitol for cystic fibrosis in the,Unite...
(Date:9/3/2008)...Disease Awareness Month, CHARLOTTESVILLE, Va., Se...C, a clinical-stage drug-development company comme...dical needs, announced today that it has begun,to ...its lead drug,candidate trans sodium crocetinate (...nicaltrials.gov Website, is investigating TSC as a...
(Date:9/3/2008)...ngo Launch Progress and Adlea ...nce Call Today at 11:30 am ET, SOUTH SAN FRANCISC...va,Inc. (Nasdaq: ANSV ) announced today that the...ommercial and late-stage product development to,ac...cal pain management,company. The company also prov...
Breaking Medicine Technology:Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Cadient Group Brings Home the Gold at 2008 Aster Awards 5261 1Cadient Group Brings Home the Gold at 2008 Aster Awards 5261 2Acrylamide Raises Kidney Cancer Risk 18890 1Acrylamide Raises Kidney Cancer Risk 18890 2Acrylamide Raises Kidney Cancer Risk 18890 3Employee Engagement 26 Retention 3A Benchmarking Metrics and Networking Opportunity to Help Solve Todays Workforce Challenges 18886 1Employee Engagement 26 Retention 3A Benchmarking Metrics and Networking Opportunity to Help Solve Todays Workforce Challenges 18886 2Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 1Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 2Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 3Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 4Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 5Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 6Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 7Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 8Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 9Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 10Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 11Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 12Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 13Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 14Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 15Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 16Warner Chilcott Reports Operating Results for the Quarter ended March 31 2008 and Updates 2008 Full Year Guidance 5259 17
...all/ -- Vical,Incorporated today announced that a ...Vaxfectin(TM) adjuvant elicited protective,levels ... old),nonhuman primates confirmed by complete prot...r vaccination, and sterilizing,immunity as evidenc...le virus after challenge. In a separate study, the...
... /PRNewswire-FirstCall/,- OncoGenex Technologies I... that preliminary data from ongoing clinical studi...ciety of Clinical,Oncology Annual Meeting (ASCO). ...inical study of OGX-011 in hormone refractory,pros...udy of,OGX-011 in non-small cell lung cancer. ASCO...
Other Medicine Technology:Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 2Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 3Vaxfectin-formulated Measles DNA Vaccine Elicits Long-term,Protection and Sterilizing Immunity in Nonhuman Primates 4OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 2OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 3OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 4
This storage freezer, which is based on our premium freezer line, maintain red cells safely below regulatory standards at -86C (-123F). Recorder is standard for model 8627. Model 8627 is UL Listed, C
...irements of blood banking and processing applicati...can Association of Blood Banks (AABB), American Na...istration (FDA) standards. Refrigerators, storage ...stems that alert you of critical power failures or...
...irements of blood banking and processing applicati...can Association of Blood Banks (AABB), American Na...istration (FDA) standards. Refrigerators, storage ...stems that alert you of critical power failures or...
This refrigerator is specially designed for the storage of blood in standard 500ml bags, complying with Australian Standard AS3864 1997. Quiet hermetic refrigeration is air-cooled utilising CFC Free
Medicine Products: